Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul;26(7):863-865.
doi: 10.1002/lt.25797.

Treating Portopulmonary Hypertension With Macitentan: Smoking Gun or Magic Bullet?

Sanjaya K Satapathy  1 , Ben L Da  2
Affiliations
Editorial

Treating Portopulmonary Hypertension With Macitentan: Smoking Gun or Magic Bullet?

Sanjaya K Satapathy et al. Liver Transpl. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006;44:1502-1510.
    1. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 2008;8:2445-2453.
    1. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, et al. International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016;100:1440-1452.
    1. Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, et al. Long-term outcome in liver transplantation candidates with portopulmonary hypertension. Hepatology 2017;65:1683-1692.
    1. Krowka M, Cottreel E, Hoeper MM, Kim NH, Martin N, Sitbon O, Bosch J. Macitentan improves risk categorization for liver transplant mortality in patients with portopulmonary hypertension: a PORTICO study post hoc analysis. Liver Transpl 2020;26:935-940.